• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FDA 在医疗移动应用程序开发中的作用。

The FDA's role in the development of medical mobile applications.

机构信息

Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.

出版信息

Clin Pharmacol Ther. 2014 May;95(5):485-8. doi: 10.1038/clpt.2014.45.

DOI:10.1038/clpt.2014.45
PMID:24747239
Abstract

The use of mobile apps is revolutionizing health-care delivery and has the potential to transform health care by allowing doctors to diagnose patients with potentially life-threatening conditions outside traditional health-care settings, as well as helping consumers manage their own health and wellness and gain access to useful information when and where they need it.

摘要

移动应用的使用正在彻底改变医疗服务的提供方式,有可能通过使医生能够在传统医疗环境之外诊断出可能危及生命的疾病,以及帮助消费者管理自己的健康和幸福,并在需要时随时随地获得有用的信息,从而改变医疗保健。

相似文献

1
The FDA's role in the development of medical mobile applications.FDA 在医疗移动应用程序开发中的作用。
Clin Pharmacol Ther. 2014 May;95(5):485-8. doi: 10.1038/clpt.2014.45.
2
Promise and challenges with the use of mobile applications to support and improve patient care: an industry perspective.移动应用程序在支持和改善患者护理方面的前景和挑战:行业视角。
Clin Pharmacol Ther. 2014 May;95(5):469-71. doi: 10.1038/clpt.2014.34.
3
Can You Diagnose Me Now? A Proposal to Modify FDA's Regulation of Smartphone Mobile Health Applications with a Pre-Market Notification and Application Database System.你现在能诊断我吗?一项关于通过上市前通知和应用程序数据库系统修改美国食品药品监督管理局对智能手机移动健康应用监管的提议。
Food Drug Law J. 2015;70(1):161-85, ii.
4
Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification With Top Health Apps in the United States: Quality Improvement Study.评估美国食品和药物管理局基于风险的软件预认证框架与顶级健康类应用:质量改进研究。
JMIR Mhealth Uhealth. 2020 Oct 26;8(10):e20482. doi: 10.2196/20482.
5
Mobile medical applications: old wine in new bottles?移动医疗应用:旧酒换新瓶?
Clin Pharmacol Ther. 2014 May;95(5):476-8. doi: 10.1038/clpt.2014.35.
6
Are we ready for apps culture?我们准备好迎接应用程序文化了吗?
Am J Orthop (Belle Mead NJ). 2011 Jul;40(7):E141-2.
7
Expanded FDA regulation of health and wellness apps.扩大 FDA 对健康和保健应用程序的监管。
Bioethics. 2020 Mar;34(3):235-241. doi: 10.1111/bioe.12674. Epub 2019 Oct 21.
8
Mobile phone-enabled control of medical care and handicapped assistance.移动电话控制医疗和残疾人援助。
Expert Rev Med Devices. 2011 Nov;8(6):757-68. doi: 10.1586/erd.11.32.
9
FDA regulation of mobile health technologies.美国食品药品监督管理局对移动健康技术的监管。
N Engl J Med. 2014 Jul 24;371(4):372-9. doi: 10.1056/NEJMhle1403384.
10
Mobile Phone Health Applications for the Federal Sector.面向联邦部门的手机健康应用程序。
US Army Med Dep J. 2016 Jan-Mar:71-5.

引用本文的文献

1
Designing an Informative App for Neurorehabilitation: A Feasibility and Satisfaction Study by Physiotherapists.为神经康复设计一款信息丰富的应用程序:物理治疗师的可行性与满意度研究
Healthcare (Basel). 2023 Sep 14;11(18):2549. doi: 10.3390/healthcare11182549.
2
Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study.评论:针对对抗抑郁药反应不足的重度抑郁症患者的基于呼吸的冥想干预:一项随机试点研究。
Front Med (Lausanne). 2017 Apr 6;4:37. doi: 10.3389/fmed.2017.00037. eCollection 2017.
3
'Can you recommend any good STI apps?' A review of content, accuracy and comprehensiveness of current mobile medical applications for STIs and related genital infections.
“你能推荐一些好的性传播感染应用程序吗?” 当前用于性传播感染及相关生殖器感染的移动医疗应用程序的内容、准确性和全面性综述
Sex Transm Infect. 2017 Jun;93(4):234-235. doi: 10.1136/sextrans-2016-052690. Epub 2016 Nov 24.
4
Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases.将天然产物、药物、自我护理以及数字/移动健康技术纳入慢性病的分子行为联合疗法。
Curr Clin Pharmacol. 2016;11(2):128-45. doi: 10.2174/1574884711666160603012237.
5
Big Data Transforms Discovery-Utilization Therapeutics Continuum.大数据改变发现-应用-治疗连续统一体。
Clin Pharmacol Ther. 2016 Mar;99(3):250-4. doi: 10.1002/cpt.322.
6
Combining non-pharmacological treatments with pharmacotherapies for neurological disorders: a unique interface of the brain, drug-device, and intellectual property.将非药物治疗与治疗神经疾病的药物疗法相结合:大脑、药物设备与知识产权的独特交汇点。
Front Neurol. 2014 Jul 14;5:126. doi: 10.3389/fneur.2014.00126. eCollection 2014.